Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

Coeptis Therapeutics closes SPAC deal with Bull Horn

AbbVie Launches ORILISSA™ (elagolix) 200 mg BID Dose for the Treatment of Moderate to Severe Pain Associated with Endometriosis

Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes - Paganoni - 2022 - Muscle & Nerve - Wiley Online Library

Novus Therapeutics acquires Anelixis Therapeutics

Novus Acquires Anelixis, Plans to Move AT-1501 Into Phase 2 Trial for ALS

Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®

Anika Therapeutics Closes Acquisition of Arthrosurface

Augie's Quest Brings ALS Drug Option to OC - Orange County Business Journal

Avidity Biosciences: Revolutionizing RNA Therapeutics Field (NASDAQ:RNA)

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

Articles about Novus Therapeutics

BioPharmCatalyst on Instagram: #Catalyst Snapshot 12/12/23: $CADL Candel Therapeutics Inc NASDAQ: CADL +59% $1.38 Announced that the FDA granted Fast Track Designation for its lead investigational adenovirus asset CAN-2409 plus prodrug (valacyclovir)

Eledon Pharmaceuticals Inc.: Registration Statement - Specified Transactions - Form S-3 - MoneyController (ID 1392787)

Rite Aid's New CEO, CommonSpirit Health Appoints First Chief Information and Digital Officer, Geisinger's Chief Nursing Exec, Other Health IT Appointments - DistilINFO LifeSciences

News & Events - Noble Capital Markets